Published on in Vol 6, No 8 (2017): August

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial

Efficacy of Lactobacillus Reuteri DSM 17938 for the Treatment of Acute Gastroenteritis in Children: Protocol of a Randomized Controlled Trial

Authors of this article:

Henryk Szymański 1 Author Orcid Image ;   Hania Szajewska 2 Author Orcid Image

Journals

  1. Oliveira A, Souza L, Araújo T, Araújo S, Nogueira K, Sousa F, Silva R, Pacífico D, Martins C, Brito G, Souza M, Medeiros J. Lactobacillus reuteri DSM 17938 Protects against Gastric Damage Induced by Ethanol Administration in Mice: Role of TRPV1/Substance P Axis. Nutrients 2019;11(1):208 View
  2. Szymański H, Szajewska H. Lack of Efficacy of Lactobacillus reuteri DSM 17938 for the Treatment of Acute Gastroenteritis. The Pediatric Infectious Disease Journal 2019;38(10):e237 View
  3. Sansotta N, Peroni D, Romano S, Rugiano A, Vuilleumier P, Baviera G. The good bugs. Current Opinion in Pediatrics 2019;31(5):661 View
  4. Naghibi M, Day R. Microbiota and infection prevention: making space for probiotics in healthcare. Gastrointestinal Nursing 2018;16(8):28 View